Skip to content

Clinical Study of Modified Zhenwu Decoction in Treating Diabetic Nephropathy of Spleen-kidney Yang Deficiency Syndrome

Clinical Study of Modified Zhenwu Decoction in Treating Diabetic Nephropathy of Spleen-kidney Yang Deficiency Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000486
Enrollment
Unknown
Registered
2025-03-07
Start date
2020-06-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic nephropathy

Interventions

control group:The control group received hypoglycemic and antihypertensive treatment.
observation group:The observation group received hypoglycemic and antihypertensive treatment plus Zhenwu Decoction for treatment.

Sponsors

Hebei Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed with diabetic nephropathy by clinical examination; (2) TCM syndrome differentiation of spleen and kidney yang deficiency type; (3) aged 18 to 65 years.

Exclusion criteria

Exclusion criteria: (1)Severe deterioration of renal function; (2)combined with malignant tumors; (3) pregnant or lactating women; (4)liver dysfunction coagulation or hematopoietic dysfunction.

Design outcomes

Primary

MeasureTime frame
TCM syndrome score;

Secondary

MeasureTime frame
serum inflammatory markers high-sensitivity C-reactive protein;whole blood viscosity;24-hour urinary protein quantification;serum creatinine;blood urea nitrogen;blood glucose;serum albumin;tumor necrosis factor;connective tissue growth factor;type IV collagen;plasma viscosity and erythrocyte aggregation index;

Countries

China

Contacts

Public ContactRen Xiaoya

Hebei Hospital of Traditional Chinese Medicine

renxiaoya064@yeah.net18633079229

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026